Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Shanghai Haohai Biological Technology Co., Ltd. Class H ( (HK:6826) ) has shared an announcement.
Shanghai Haohai Biological Technology Co., Ltd. has announced proposed amendments to its Articles of Association, which include abolishing the supervisory committee and transferring its responsibilities to the audit committee. These changes align with recent regulatory updates in China and Hong Kong, aiming to streamline governance structures and incorporate electronic voting and hybrid shareholder meetings. The amendments are subject to shareholder approval at the upcoming annual general meeting.
More about Shanghai Haohai Biological Technology Co., Ltd. Class H
Shanghai Haohai Biological Technology Co., Ltd. is a company based in China, operating in the biotechnology industry. The company focuses on developing and providing biological materials and medical devices.
Average Trading Volume: 585,957
Technical Sentiment Signal: Sell
Current Market Cap: HK$12.06B
For a thorough assessment of 6826 stock, go to TipRanks’ Stock Analysis page.